MiMedx Group Inc

MDXG · Moat type: REGULIERUNG

MoatScore

4/10

Fair Value

9 USD

Margin of Safety

+51.8 %

Rating

BEOBACHTEN

MiMedx Group develops and markets tissue products based on human amniotic membrane (placental tissue), which are primarily used in wound care, orthopedics, and ophthalmology and are sold through a direct distribution network to clinics, hospitals, and ambulatory care providers.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.